Literature DB >> 29947353

Clinical Characteristics of Children and Adolescents Undergoing Hematopoietic Cell Transplantation Who Develop Oral Mucositis.

Clare Donohoe1, Judy K Bosi2, April Sykes2, Zhaohua Lu, Belinda Mandrell2.   

Abstract

OBJECTIVES: To describe the clinical characteristics of children and adolescents undergoing hematopoietic cell transplantation (HCT) who develop oral mucositis. SAMPLE &
SETTING: 45 patients who underwent HCT from July 2015 to May 2016 at St. Jude Children's Research Hospital in Memphis, Tennessee. METHODS & VARIABLES: Clinical factors were described as transplantation type, mucositis severity or grade, mucositis duration, days to engraftment, total parenteral nutrition (TPN) support, IV opioid pain management use during mucositis, positive blood or oral cultures, and length of hospitalization, then compared across mucositis grade.
RESULTS: 24 patients had grade 3 or greater mucositis onset from day -3 to day 9 of transplantation; of these, 23 required IV opioid medication to treat mucosal pain. Patients with mucositis grade 3 or greater were more likely to have undergone an allogeneic transplantation, receive TPN, have documented positive blood or oral cultures, and have longer hospitalizations than those with low-grade mucositis. IMPLICATIONS FOR NURSING: Nurses are in a unique position to propose and administer interventions to prevent and alleviate symptoms of mucositis.

Entities:  

Keywords:  children and adolescents; hematopoietic cell transplantation; oral mucositis

Mesh:

Substances:

Year:  2018        PMID: 29947353      PMCID: PMC6152915          DOI: 10.1188/18.ONF.457-462

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  14 in total

1.  Patient reports of complications of bone marrow transplantation.

Authors:  L A Bellm; J B Epstein; A Rose-Ped; P Martin; H J Fuchs
Journal:  Support Care Cancer       Date:  2000-01       Impact factor: 3.603

2.  Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.

Authors:  S T Sonis; G Oster; H Fuchs; L Bellm; W Z Bradford; J Edelsberg; V Hayden; J Eilers; J B Epstein; F G LeVeque; C Miller; D E Peterson; M M Schubert; F K Spijkervet; M Horowitz
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

3.  The prevention of induced oral mucositis with low-level laser therapy in bone marrow transplantation patients: a randomized clinical trial.

Authors:  Geisa Badauy Lauria Silva; Elismauro Francisco Mendonça; Cesar Bariani; Heliton Spindola Antunes; Maria Alves Garcia Silva
Journal:  Photomed Laser Surg       Date:  2010-10-22       Impact factor: 2.796

Review 4.  Oral mucositis.

Authors:  Judith E Raber-Durlacher; Sharon Elad; Andrei Barasch
Journal:  Oral Oncol       Date:  2010-04-18       Impact factor: 5.337

5.  Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy.

Authors:  Fernanda de Paula Eduardo; Leticia Mello Bezinelli; Danielle Lima Corrêa de Carvalho; Roberta Marques da Graça Lopes; Juliana Folloni Fernandes; Melina Brumatti; Carolina Sgaroni Camargo Vince; Alessandra Milani Prandini de Azambuja; Cristina Vogel; Nelson Hamerschlak; Luciana Correa
Journal:  Pediatr Transplant       Date:  2015-02-13

Review 6.  Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.

Authors:  Stephen T Sonis; Linda S Elting; Dorothy Keefe; Douglas E Peterson; Mark Schubert; Martin Hauer-Jensen; B Nebiyou Bekele; Judith Raber-Durlacher; J Peter Donnelly; Edward B Rubenstein
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

7.  Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors:  Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

8.  A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation.

Authors:  Mark M Schubert; Fernanda P Eduardo; Katherine A Guthrie; Jean-Claude Franquin; Rene-Jean J Bensadoun; Cesar A Migliorati; C Michele E Lloid; Carlos P Eduardo; Niccoli-Filho Walter; Marcia M Marques; Mohd Hamdi
Journal:  Support Care Cancer       Date:  2007-03-29       Impact factor: 3.603

9.  Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: a retrospective study.

Authors:  E Bardellini; F Schumacher; G Conti; F Porta; G Campus; A Majorana
Journal:  Pediatr Transplant       Date:  2013-06-10

Review 10.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860

View more
  1 in total

1.  The Association Between Pain Relief Using Video Games and an Increase in Vagal Tone in Children With Cancer: Analytic Observational Study With a Quasi-Experimental Pre/Posttest Methodology.

Authors:  Mario Alonso Puig; Mercedes Alonso-Prieto; Jordi Miró; Raquel Torres-Luna; Diego Plaza López de Sabando; Francisco Reinoso-Barbero
Journal:  J Med Internet Res       Date:  2020-03-30       Impact factor: 5.428

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.